OM Pharma SA
- Country
- 🇨🇭Switzerland
- Ownership
- Subsidiary
- Established
- 1937-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.ww.ompharma.com
Clinical Trials
19
Trial Phases
3 Phases
Drug Approvals
2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- OM Pharma SA
- Target Recruit Count
- 41
- Registration Number
- NCT06486662
- Locations
- 🇩🇪
The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM, Hanover, Germany
A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing
- Conditions
- Recurrent WheezingWheezing Lower Respiratory Illness
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- OM Pharma SA
- Target Recruit Count
- 288
- Registration Number
- NCT05857930
- Locations
- 🇺🇸
Arizona Medical Clinic, Phoenix, Arizona, United States
🇺🇸Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸The University of Arizona Medical Center - University Campus, Tucson, Arizona, United States
OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
- Conditions
- Wheezing Lower Respiratory IllnessRespiratory Tract Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-01-10
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- OM Pharma SA
- Target Recruit Count
- 525
- Registration Number
- NCT05677763
- Locations
- 🇵🇱
Podkarpacki Osrodek Pulmonologii i Alergologii Sp. z o.o., Rzeszow, Poland
🇬🇧Nottingham University Hospitals NHS Trust - Queen's Medical Centre, Nottingham, United Kingdom
🇩🇪Ludwig Maximilians Universität München, München, Bayern, Germany
Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- OM Pharma SA
- Target Recruit Count
- 63
- Registration Number
- NCT05222516
- Locations
- 🇫🇷
Centre d'investigation clinique GHE, Bron, France
🇫🇷CHU de Cote de Nacre, Centre de Recherche Clinique Pediatric, Caen, France
🇫🇷Hopital Hotel Dieu, Nantes, France